| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/29/2002 | US20020120004 Determining the level of expression in cancer cells of a marker and identifying that an agent can be used as anticancer agent when the marker is expressed at a certain level |
| 08/29/2002 | US20020120003 Methods for decreasing beta amyloid protein |
| 08/29/2002 | US20020119989 Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction |
| 08/29/2002 | US20020119945 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof |
| 08/29/2002 | US20020119927 Protein-protein interactions in neurodegenerative diseases |
| 08/29/2002 | US20020119919 Nucleic acids, proteins, and antibodies |
| 08/29/2002 | US20020119911 Testing drug for cognition activators, sedatives, anxiolytic agents, anticonvulsants; calibration |
| 08/29/2002 | US20020119582 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 08/29/2002 | US20020119581 Indicator systems which may undergo a molecular configurational change upon exposure to a polyhydroxyl analyte |
| 08/29/2002 | US20020119579 Protein-capture agents useful for the simultaneous detection of a plurality of proteins which are the expression products or fragments of a cell or population of cells in an organism |
| 08/29/2002 | US20020119575 Microwave drying and nuclear magnetic resonance analysis; quality control |
| 08/29/2002 | US20020119574 Rinsing/disinfecting with hydrogen peroxide/peracetic acid and determining electroconductivity for detection of microbes; for use on dairy farm |
| 08/29/2002 | US20020119565 Isolation and use of solid tumor stem cells |
| 08/29/2002 | US20020119564 Selecting cells that express a known marker, such as proteins expressed by genes encoding the major histocomatibility complex |
| 08/29/2002 | US20020119561 Microbiological test array with flat base having plurality of upwardly projecting microwells connected by microchannel to open reservoir formed in surface parallel to base of test array; for use in automated analyzers |
| 08/29/2002 | US20020119560 Device for measuring cell invasion and method therefor |
| 08/29/2002 | US20020119559 Low fluorescence nylon/glass composites for micro-analytical diagnostic applications |
| 08/29/2002 | US20020119548 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/29/2002 | US20020119530 Method of increasing product expression through solute stress |
| 08/29/2002 | US20020119526 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 08/29/2002 | US20020119525 TAB1 protein and DNA coding therefore |
| 08/29/2002 | US20020119524 Novel molecules of the T129-related protein family and uses thereof |
| 08/29/2002 | US20020119523 Nucleotide sequences coding polypeptides for use in the treatment of cancer, nervous system and blood disorders |
| 08/29/2002 | US20020119520 Polypeptide for use in the screening of bactericides and preventing infections |
| 08/29/2002 | US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders |
| 08/29/2002 | US20020119518 Peptide for use in treatment and diagnosis of heart defects |
| 08/29/2002 | US20020119517 Detection of modulators of body weight; obtain cell samples, monitor expression of preferenial genes, incubate with modulators, compare to control, monitor adjustment in body weight |
| 08/29/2002 | US20020119513 Method and apparatus for the detection of volatile products in a sample |
| 08/29/2002 | US20020119510 Enzymatic polypeptide for use in screening bactericides |
| 08/29/2002 | US20020119505 Monitoring phosphorylation states of one or more proteins; obtain protein sample, incubate with label, monitor sample for signal from bound proteins |
| 08/29/2002 | US20020119504 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 08/29/2002 | US20020119503 Flow cytometry reagent and system |
| 08/29/2002 | US20020119502 Screening drugs for use in the treatment of mammary gland cancer; obtain animal, inject or orally administer anticarcinogeneic agent, monitor animal for development of cancer |
| 08/29/2002 | US20020119500 Multiplexed enzymatic assays |
| 08/29/2002 | US20020119499 Detecting modulators of membrane protein activities; obtain membrane protein sample, incubtae with modulator, detect adjustment in membrane activity |
| 08/29/2002 | US20020119498 Detection dimerizing test polypeptide; obtain population of genetically engineered cells, express vector, isolate cells expressing desired concentration of reporter molecule |
| 08/29/2002 | US20020119497 Detecting or measurement of preferential analyte in sample; obtain sample, incubate with hapten binding agent, detect bound particles |
| 08/29/2002 | US20020119496 Nuclear magnetic resonance screening method |
| 08/29/2002 | US20020119494 Detection of modulators for the treatment chronic obstructive pulmonary disease; obtain sample containing membrane protein, incubate with modulator, monitor membrane protein activity |
| 08/29/2002 | US20020119492 Modulating immunogenicity of a target protein; obtain protein sequence, record in computer, screen library for preferental amino acid sequences |
| 08/29/2002 | US20020119491 Monitoring therapeutic levels of S-adenosylmethionine in fluid sample; obtain sample containing enzymatic polypeptides and glycine, measure concentration of preferential reaction products compare to s-adenosylmethionine |
| 08/29/2002 | US20020119490 Methods for rapid and quantitative proteome analysis |
| 08/29/2002 | US20020119486 Apparatus for use in the detection of preferential particles in liquids |
| 08/29/2002 | US20020119485 Detect preferential particle in sample by luminescence; obtain sample, incubate with probes, irradiate, detect luminescence |
| 08/29/2002 | US20020119483 Methods for detection of chloral hydrate in dichloroacetic acid |
| 08/29/2002 | US20020119482 Microfluidic apparatus for use in high throughput screening for genomics and human therapeutics |
| 08/29/2002 | US20020119481 Method and apparatus to identify small variations of biomolecules |
| 08/29/2002 | US20020119479 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant GPIIb allele |
| 08/29/2002 | US20020119476 Nucleotide sequences coding membrane protin for use in the treatment of schizophrenia, depression, anxiety, attention deficit hyperactivity disorder, headaches, strokes, ischemia, vision defects, epilepsy and nervous system disorders |
| 08/29/2002 | US20020119472 Methods for disease diagnosis from stool samples |
| 08/29/2002 | US20020119463 Prostate cancer markers |
| 08/29/2002 | US20020119459 Optical sorting method |
| 08/29/2002 | US20020119455 Methods and products for analyzing polymers |
| 08/29/2002 | US20020119453 HO-1 as a diagnostic and prognostic test for dementing diseases |
| 08/29/2002 | US20020119450 Fluorimetric detection system of a nucleic acid |
| 08/29/2002 | US20020119447 Non-a,non-b,non-c,non-c,non-d,non-e hepatitis reagents and methods for their use |
| 08/29/2002 | US20020119446 Screening viricides for use in the treatment of respiratory syncytial viral infections; obtain sample of virus, incubate with viricides, generate transcripts, compare transcrips to those generated in the absence of viricide |
| 08/29/2002 | US20020119443 Screening preferential prodrugs for use in viral therapy; obtain target tissue, incubate with prodrug, monitor and evaluate prodrug activity in tissues |
| 08/29/2002 | US20020119441 Method of characterizing potential therapeutics by determining cell-cell interactions |
| 08/29/2002 | US20020119167 Human adamts-1 protein, gene coding the same, pharmaceutical composition, and method for immunologically assaying human adamts-1 protein |
| 08/29/2002 | US20020119157 For cancer therapy |
| 08/29/2002 | US20020119155 Protein-protein interactions in neurodegenerative diseases |
| 08/29/2002 | US20020119154 For diagnosing diseases associated with somatolactogenic functions in patients |
| 08/29/2002 | US20020119149 Multivalent T cell receptor complexes |
| 08/29/2002 | US20020119148 ErbB4 antagonists |
| 08/29/2002 | US20020119140 For regulation of growth of neurons in the Central Nervous System |
| 08/29/2002 | US20020119137 Useful in treating metabolic disorders or disorders associated with changes in adipose tissue physiological function or mass |
| 08/29/2002 | US20020119130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | US20020119121 Compositions and methods for inducing specific cytolytic T cell responses |
| 08/29/2002 | US20020119099 Administering a recombinant tumor cell that expresses a secretable exogenous marker protein, measuring the amount of that protein in the urine, which is proportional to the number of viable tumor cells; device to collect mouse urine |
| 08/29/2002 | US20020119095 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours |
| 08/29/2002 | US20020119078 Fluid interface couples the microfluidics of the cartridge to the microfluidics of the external system with little or no dead volume |
| 08/29/2002 | US20020119076 Spindle head assembly interconnected between first and second lateral support members; spindle head assembly is movable to enhance access |
| 08/29/2002 | US20020118435 Chemical compositions comprising crystalline colloidal arrays |
| 08/29/2002 | US20020118364 Detection of trace levels of water |
| 08/29/2002 | US20020118354 Method for measuring the volume of individual red blood cells |
| 08/29/2002 | US20020118353 Apparatus for measuring the volume of individual red blood cells |
| 08/29/2002 | US20020118296 Integrated multi-format audio/video production system |
| 08/29/2002 | US20020118025 Piping fluid decision device and piping fluid control system |
| 08/29/2002 | US20020118005 Single-molecule detector |
| 08/29/2002 | US20020117659 Nanosensors |
| 08/29/2002 | US20020117453 High density nickel particles for separation and isolation of prions, viruses, bacteria and protozoa from biological fluids |
| 08/29/2002 | US20020117403 For measuring iodide in urine with ion selective electrode and electronic meter |
| 08/29/2002 | US20020117274 Fluorescence microscopy technique for measuring physical and chemical properties of individual fiber like particles |
| 08/29/2002 | US20020116987 Apparatus and methods for measuring extensional rheological properties of a material |
| 08/29/2002 | US20020116983 Electronic odor sensor |
| 08/29/2002 | US20020116980 Roll defect management process |
| 08/29/2002 | DE10204416A1 Benthisches Messgerät zur Einmalverwendung Benthic meter for single use |
| 08/29/2002 | DE10107083A1 Pentosan Polysulfat als Ligand zum Nachweis von Prionen Pentosan polysulfate as a ligand for the detection of prions |
| 08/29/2002 | CA2799371A1 Optoelectronic detection system |
| 08/29/2002 | CA2750033A1 Methods and probes for the detection of cancer |
| 08/29/2002 | CA2737095A1 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 08/29/2002 | CA2476397A1 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | CA2440830A1 Method for detecting tse-induced modifications in the human and animal body |
| 08/29/2002 | CA2440008A1 Rat toxicologically relevant genes and uses thereof |
| 08/29/2002 | CA2439235A1 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 08/29/2002 | CA2438818A1 Rapid production of monoclonal antibodies |
| 08/29/2002 | CA2438811A1 Monitoring soluble endothelial protein c receptor levels in anticoagulant therapy |
| 08/29/2002 | CA2438740A1 Drug metabolizing enzymes |
| 08/29/2002 | CA2438633A1 Method and means for determining fitness in plants |